Volume 21 - Issue 7 - July 2008
Technology In Practice »
Can the natural oak extract Oakin™ enhance the healing properties of a wound dressing? AmeriGel Wound Dressing (AmerX Health Care), which contains Oakin, has received high marks from podiatrists for its ability to promote healing, especially following nail surgeries.
The company notes that AmeriGel Wound Dressing reduces wound bioburden through its antimicrobial and antifungal properties, and assists in debridement. The dressing also reportedly balances the mix of matrix metalloproteinases (MMPs) and tissue inhibitory matrix proteins (TIMPs) in the wound matrix
New Products »
A new bootie can offer cold therapy for patients suffering from various conditions.
The NatraCare Cold Therapy Bootie has three pockets that allow patients to place cold packs around the heel, ball of the foot or the top of the feet, according to the manufacturer GelSmart/ PediFix.
The company says the booties can help ease chronic heel pain, Achilles tendonitis and low ankle sprains. In addition, patients can get relief from inflammation due to arthritis and strains from minor sports injuries. The company says patients can refrigerate
Continuing Education »
Please click here for the full Continuing Medical Education article:
Given the challenges of treating puncture wounds, these authors emphasize a thorough diagnostic work-up, review pertinent guidelines and explore current concepts on the use of prophylactic antibiotics.
Diabetic foot ulcers are among the many complications encountered with poorly controlled diabetes mellitus. Approximately 15 percent of all patients with diabetes will experience an ulcer in their lifetimes.1,2 Additionally, 85 percent of all nontraumatic lower extremity amputations are preceded by a preventable ulceration.3,4
Diabetic foot ulcerations pose a considerable economic burden. In 1995, Medicare spent $1.5 billion on diabetic lower extremity ulcers.5 One retrospective analysis found that foot ulc
I have just finished reading the article, “EBM: Can It Be A Reality In Practice?” (see page 38 in the May issue).
I acknowledge and understand the viewpoints presented in the article.
However, if we all waited for articles to be peer reviewed before trying a new treatment, how would this help patients currently? When a new technology or modality appears, and it is presented in a journal that is not peer reviewed, should we be skeptical of using the modality on our patients?
Someone has to take the initiative to try the new product and report back to
Our contemporary knowledge and critical limb ischemia (CLI) tools have allowed us to dispel many myths regarding the endovascular treatments of lower extremity disease and CLI. These tools are not perfect but they have greatly improved over the last decade and certainly over the last two to three years. One of the biggest complaints I hear from podiatrists is “the surgeons and interventionalists in my area do not believe these things work.” Accordingly, let us take a closer look at some of these myths and the corresponding realities.
Myth: Most CLI patien
- « Previous
- | Page 1 of 3 |
- Next »